Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Regeneron Pharmaceuticals, Inc.(REGN) | 14,476 | 31,500 | +17,024 | $15.22M | $22.44M | 9.19% | +$7.22M |
| Johnson & Johnson(JNJ) | 0 | 141,572 | +141,572 | $0 | $20.47M | 8.39% | +$20.47M |
| Royalty Pharma plcCL A(RPRX) | 664,859 | 764,859 | +100,000 | $18.81M | $19.51M | 8.00% | +$702.7K |
| AbbVie Inc.(ABBV) | 0 | 101,996 | +101,996 | $0 | $18.12M | 7.43% | +$18.12M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 286,803 | 406,803 | +120,000 | $15.93M | $17.11M | 7.01% | +$1.18M |
| BridgeBio Pharma, Inc.(BBIO) | 396,388 | 560,344 | +163,956 | $10.09M | $15.38M | 6.30% | +$5.28M |
| Sarepta Therapeutics, Inc.(SRPT) | 83,756 | 124,256 | +40,500 | $10.46M | $15.11M | 6.19% | +$4.65M |
| Insmed Incorporated(INSM) | 215,884 | 210,884 | -5,000 | $15.76M | $14.56M | 5.97% | -$1.20M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 0 | 584,883 | +584,883 | $0 | $12.89M | 5.28% | +$12.89M |
| Viridian Therapeutics, Inc.(VRDN) | 518,677 | 628,677 | +110,000 | $11.80M | $12.05M | 4.94% | +$251.8K |
| Amgen Inc.(AMGN) | 0 | 38,090 | +38,090 | $0 | $9.93M | 4.07% | +$9.93M |
| Agios Pharmaceuticals, Inc.(AGIO) | 186,623 | 301,623 | +115,000 | $8.29M | $9.91M | 4.06% | +$1.62M |
| Vera Therapeutics, Inc.CL A(VERA) | 172,876 | 212,696 | +39,820 | $7.64M | $8.99M | 3.69% | +$1.35M |
| Newamsterdam Pharma Company ORDINARY SHARES | 0 | 337,152 | +337,152 | $0 | $8.66M | 3.55% | +$8.66M |
| Moderna, Inc.(MRNA) | 0 | 197,500 | +197,500 | $0 | $8.21M | 3.37% | +$8.21M |
| Perrigo Company plcSHS(PRGO) | 557,937 | 294,517 | -263,420 | $14.63M | $7.57M | 3.10% | -$7.06M |
| Janux Therapeutics, Inc.(JANX) | 0 | 120,000 | +120,000 | $0 | $6.42M | 2.63% | +$6.42M |
| Akero Therapeutics Inc | 0 | 230,000 | +230,000 | $0 | $6.40M | 2.62% | +$6.40M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 0 | 112,500 | +112,500 | $0 | $6.23M | 2.55% | +$6.23M |
| Centessa Pharmaceuticals PlcADS | 0 | 147,076 | +147,076 | $0 | $2.46M | 1.01% | +$2.46M |
| Neumora Therapeutics, Inc.(NMRA) | 0 | 150,000 | +150,000 | $0 | $1.59M | 0.65% | +$1.59M |
| Agilent Technologies, Inc.(A) | 120,485 | 0 | -120,485 | $17.89M | $0 | — | -$17.89M |
| Arcellx Inc COMMON STOCK | 89,863 | 0 | -89,863 | $7.50M | $0 | — | -$7.50M |
| Avadel Pharmaceuticals Plc | 385,172 | 0 | -385,172 | $5.05M | $0 | — | -$5.05M |
| Avidity Biosciences Inc | 160,947 | 0 | -160,947 | $7.39M | $0 | — | -$7.39M |
| Axsome Therapeutics, Inc.(AXSM) | 105,767 | 0 | -105,767 | $9.51M | $0 | — | -$9.51M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 798,137 | 0 | -798,137 | $6.07M | $0 | — | -$6.07M |
| Bristol-Myers Squibb Company(BMY) | 574,057 | 0 | -574,057 | $29.70M | $0 | — | -$29.70M |
| Eli Lilly and Company(LLY) | 17,299 | 0 | -17,299 | $15.33M | $0 | — | -$15.33M |
| Enliven Therapeutics Inc | 207,896 | 0 | -207,896 | $5.31M | $0 | — | -$5.31M |
| Gilead Sciences, Inc.(GILD) | 359,025 | 0 | -359,025 | $30.10M | $0 | — | -$30.10M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 376,315 | 0 | -376,315 | $15.05M | $0 | — | -$15.05M |
| Intellia Therapeutics, Inc.(NTLA) | 390,622 | 0 | -390,622 | $8.03M | $0 | — | -$8.03M |
| Ionis Pharmaceuticals, Inc.(IONS) | 97,300 | 0 | -97,300 | $3.90M | $0 | — | -$3.90M |
| Iovance Biotherapeutics, Inc.(IOVA) | 876,009 | 0 | -876,009 | $8.23M | $0 | — | -$8.23M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 117,500 | 0 | -117,500 | $13.09M | $0 | — | -$13.09M |
| Legend Biotech CorporationADS(LEGN) | 325,953 | 0 | -325,953 | $15.88M | $0 | — | -$15.88M |
| Springworks Therapeutics Inc | 378,453 | 0 | -378,453 | $12.13M | $0 | — | -$12.13M |